LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.

LABT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
S-1 May 1, 2026 REGISTRATION STATEMENT
424B3 Apr 30, 2026 PROSPECTUS SUPPLEMENT
8-K Apr 28, 2026 CURRENT REPORT
424B4 Apr 23, 2026 PROSPECTUS
CERT Apr 22, 2026
EFFECT Apr 17, 2026
8-A12B Apr 17, 2026 FOR REGISTRATION OF CERTAIN CLASSES
S-1/A Apr 6, 2026 REGISTRATION STATEMENT
S-1/A Apr 1, 2026 REGISTRATION STATEMENT
S-1/A Mar 11, 2026 REGISTRATION STATEMENT
S-1/A Feb 13, 2026 REGISTRATION STATEMENT
S-1/A Feb 5, 2026 REGISTRATION STATEMENT
S-1 Jan 9, 2026 REGISTRATION STATEMENT
DRS/A Oct 17, 2025
DRS Jul 31, 2025
← Newer Page 2 of 2 · 40 filings Older →